Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.913
+0.014 (1.58%)
Nov 21, 2024, 12:44 PM EST - Market open

Tempest Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
24851236--
Market Cap Growth
769.27%600.22%-66.85%---
Enterprise Value
1995-14-4--
Last Close Price
0.904.401.155.28--
PB Ratio
2.083.160.671.01--
P/TBV Ratio
3.083.160.671.01--
Debt / Equity Ratio
1.550.771.220.510.141.47
Quick Ratio
1.584.174.292.595.840.90
Current Ratio
1.694.294.533.446.151.04
Return on Equity (ROE)
-691.89%-131.42%-131.70%-104.76%-196.78%-
Return on Assets (ROA)
-77.01%-37.31%-36.29%-35.10%-79.27%-
Return on Capital (ROIC)
-90.85%-41.58%-45.64%-44.97%-99.17%-
Earnings Yield
-150.82%-34.82%-295.25%-77.57%--
FCF Yield
-125.23%-32.50%-261.55%-71.51%--
Buyback Yield / Dilution
-61.11%-33.49%-204.70%-709.62%44.17%-
Total Shareholder Return
-61.11%-33.49%-204.70%-709.62%44.17%-
Source: S&P Capital IQ. Standard template. Financial Sources.